These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39013375)

  • 1. Evaluation of the International Task Force for Disease Eradication: A Review of Past Deliberations.
    Sadiq S; Kajani UA; Travers AR; Hopkins DR; Richards F; Ijaz K
    Am J Trop Med Hyg; 2024 Sep; 111(3_Suppl):5-11. PubMed ID: 39013375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the International Task Force for Disease Eradication.
    MMWR Recomm Rep; 1993 Dec; 42(RR-16):1-38. PubMed ID: 8145708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting of the International Task Force for Disease Eradication – November 2012.
    Wkly Epidemiol Rec; 2013 Feb; 88(7):75-80. PubMed ID: 23540049
    [No Abstract]   [Full Text] [Related]  

  • 4. Global programme to eliminate lymphatic filariasis: progress report, 2013.
    Wkly Epidemiol Rec; 2014 Sep; 89(38):409-18. PubMed ID: 25243263
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors Influencing the Sustainability of Neglected Tropical Disease Elimination Programs: A Multi-Case Study of the Kenya National Program for Elimination of Lymphatic Filariasis.
    Thuo IW; Ndiaye K; Mookherji S
    Am J Trop Med Hyg; 2020 May; 102(5):1090-1093. PubMed ID: 32124717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: International Task Force for Disease Eradication, 1990 and 1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jan; 41(3):40-2. PubMed ID: 1731181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global programme to eliminate lymphatic filariasis: progress report, 2016.
    Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
    [No Abstract]   [Full Text] [Related]  

  • 8. Is vector control needed to eliminate gambiense human African trypanosomiasis?
    Solano P; Torr SJ; Lehane MJ
    Front Cell Infect Microbiol; 2013; 3():33. PubMed ID: 23914350
    [No Abstract]   [Full Text] [Related]  

  • 9. Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.
    Bailey TC; Merritt MW; Tediosi F
    Am J Public Health; 2015 Apr; 105(4):629-36. PubMed ID: 25713967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope.
    Masiyiwa T; Bockarie MJ
    Int J Infect Dis; 2024 Mar; 140():102-103. PubMed ID: 38280664
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostics for the control and elimination of neglected tropical diseases.
    Peeling RW; Mabey D
    Parasitology; 2014 Dec; 141(14):1789-94. PubMed ID: 25248096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: International Task Force for Disease Eradication, 1992.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(37):691, 697-8. PubMed ID: 1518501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Spatial Statistics in the Control and Elimination of Neglected Tropical Diseases in Sub-Saharan Africa: A Focus on Human African Trypanosomiasis, Schistosomiasis and Lymphatic Filariasis.
    Stanton MC
    Adv Parasitol; 2017; 97():187-241. PubMed ID: 28325371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Lymphatic Filariasis Be Eliminated by 2020?
    Rebollo MP; Bockarie MJ
    Trends Parasitol; 2017 Feb; 33(2):83-92. PubMed ID: 27765440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases.
    Hotez P
    Vaccine; 2011 Dec; 29 Suppl 4():D104-10. PubMed ID: 22188933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic filariasis in Asia: a systematic review and meta-analysis.
    Bizhani N; Hashemi Hafshejani S; Mohammadi N; Rezaei M; Rokni MB
    Parasitol Res; 2021 Feb; 120(2):411-422. PubMed ID: 33415391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies.
    Prada JM; Stolk WA; Davis EL; Touloupou P; Sharma S; Muñoz J; Caja Rivera RM; Reimer LJ; Michael E; de Vlas SJ; Hollingsworth TD
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):261-268. PubMed ID: 33515454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
    Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges.
    Tediosi F; Steinmann P; de Savigny D; Tanner M
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2446. PubMed ID: 24244762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.